Skip to main content
. 2025 Mar 28;17(7):1131. doi: 10.3390/cancers17071131
3D-CRT Three-dimensional conformal radiotherapy
AC Anthracycline, cyclophosphamide
AI Aromatase inhibitor
BCS Breast-conserving surgery
CI Confidence intervals
IMRT Intensity-modulated radiation therapy
INC Instituto Nacional de Cancerología
IQR Interquartile range
NACT Neoadjuvant chemotherapy
OS Overall survival
pCR Pathologic complete response
RT Adjuvant radiotherapy
SD Standard deviation
T Taxanes
TC Taxane and cyclophosphamide
TH Taxanes and trastuzumab
TR Time to recurrence
VMAT Volumetric intensity-modulated arc therapy